Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRPT | BGNE | INCY | ||
| Company | Sarepta Therapeutics | Beigene Ltd ADR | Incyte Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 127.06 | 154.30 | 51.87 | ||
| High | 131.61 | 157.89 | 53.98 | ||
| Low | 127.00 | 154.30 | 51.75 | ||
| Last | 130.90 | 156.53 | 52.94 | ||
| Change | +4.24 | +2.59 | +0.89 | ||
| % Change | +3.35% | +1.68% | +1.71% | ||
| Volume | 1,186,200 | 176,900 | 3,575,500 | ||
| 20-Day Average Volume | 801,765 | 198,420 | 1,994,280 | ||
| Previous Close | 126.66 | 153.94 | 52.05 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 123.27 | 144.48 | 53.23 | ||
| 20-Day Raw Stochastic | 94.84% | 95.60% | 42.39% | ||
| 20-Day Relative Strength | 59.89% | 54.46% | 40.45% | ||
| Weighted Alpha | +18.38 | -33.87 | -20.98 | ||
| Today's Opinion | 88% Buy | 64% Sell | 100% Sell | ||
| Previous Opinion | 88% Buy | 80% Sell | 100% Sell | ||
| Last Month's Opinion | 56% Buy | 80% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.35% since 04/24/24 | +8.61% since 04/24/24 | +2.32% since 04/24/24 | ||
| Low | 121.80 on 04/25/24 | 146.16 on 04/25/24 | 50.35 on 04/30/24 | ||
| High | 131.80 on 04/29/24 | 157.89 on 05/01/24 | 53.98 on 05/01/24 | ||
| 1-Month | |||||
| %Chg | +1.95% since 04/01/24 | -1.70% since 04/01/24 | -6.53% since 04/01/24 | ||
| Low | 114.37 on 04/19/24 | 126.97 on 04/19/24 | 50.35 on 04/30/24 | ||
| High | 131.80 on 04/29/24 | 157.89 on 05/01/24 | 57.15 on 04/02/24 | ||
| 3-Month | |||||
| %Chg | +6.57% since 02/01/24 | +4.40% since 02/01/24 | -10.51% since 02/01/24 | ||
| Low | 114.37 on 04/19/24 | 126.97 on 04/19/24 | 50.35 on 04/30/24 | ||
| High | 143.00 on 02/16/24 | 184.80 on 03/13/24 | 61.87 on 02/23/24 | ||
| 6-Month | |||||
| %Chg | +71.07% since 11/01/23 | -13.66% since 11/01/23 | -2.63% since 11/01/23 | ||
| Low | 75.69 on 11/02/23 | 126.97 on 04/19/24 | 50.35 on 04/30/24 | ||
| High | 143.00 on 02/16/24 | 205.40 on 11/14/23 | 67.36 on 01/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,970,129 | 14,722,820 | 11,686,579 | ||
| Shares Outstanding, K | 94,506 | 95,640 | 224,526 | ||
| Annual Sales | 1,243,340,000 | 2,458,780,000 | 3,695,650,000 | ||
| Annual Net Income | -535,980,000 | -881,710,000 | 597,600,000 | ||
| Last Quarter Sales | 396,780,000 | 634,410,000 | 1,013,340,000 | ||
| Last Quarter Net Income | 45,650,000 | -367,550,000 | 201,080,000 | ||
| 60-Month Beta | 0.94 | 0.61 | 0.65 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.47 on 02/28/24 | -3.53 on 02/26/24 | 1.06 on 02/13/24 | ||
| Latest Earnings Date | 05/01/24 | 05/02/24 | 04/30/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 19.61 | ||